Helen Byomire Ndagije (Helen B Ndagije)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Venues

Drug safety

Antibiotics (Basel, Switzerland)

Expert opinion on drug safety

PloS one

National Drug Authority

Université Catholique de Louvain (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Drug Authority Jul 01 2017

Uganda

Director :: Product Safety

National Drug Authority Apr 03 2006 - Jun 30 2017

Uganda

Head :: Drug Information Department

Uganda Virus Research Institute

Uganda

Development of Anti-retroviral Therapy (DART) Trial Manager :: Medical Research Council, Uganda

Uganda Virus Research Institute

Uganda

Clinical Trial Coordinator, PRO 2000 Microbicide gel Study :: Medical Research Council Programme on AIDS in Uganda

Education History

Université Catholique de Louvain

Belgium

PHD :: School of Public Health

Makerere University School of Medicine

Uganda

MSC :: Faculty of Medicine

Publications

Manal Mohammed Younus, Mayada Alkhakany, Priya Bahri, Angela Caro-Rojas, Hadir Rostom, Helen Byomire Ndagije, Mohamed A Elhawary
The ISoP PatEG-SIG for Promoting Patient Engagement in Pharmacovigilance: A Change of Paradigm is Needed. Drug safety (2023)
Mohamed A Elhawary, Comfort Kunak Ogar, Mónica Tarapués, Angela Caro-Rojas, Helen Byomire Ndagije, Ghita Benabdallah, Houda Sefiani, Hadir Rostom
The Role of ISoP in the Advancement of Pharmacovigilance in Low-and Middle-Income Countries (LMICs). Drug safety (2023)
Helen Byomire Ndagije, David Walusimbi, Joanita Atuhaire, Sheila Ampaire
Drug safety in Africa: a review of systems and resources for pharmacovigilance. Expert opinion on drug safety (2023)
Paul Kutyabami, Edson Ireeta Munanura, Rajab Kalidi, Sulah Balikuna, Margaret Ndagire, Bruhan Kaggwa, Winnie Nambatya, Pakoyo Fadhiru Kamba, Allan Musiimenta, Diana Nakitto Kesi, Victoria Nambasa, Allan Serwanga, Helen Byomire Ndagije
Evaluation of the Clinical Use of Ceftriaxone among In-Patients in Selected Health Facilities in Uganda. Antibiotics (Basel, Switzerland) 10 (7) (2021)
Victoria Nambasa, Helen Byomire Ndagije, Allan Serwanga, Leonard Manirakiza, Joanitah Atuhaire, Diana Nakitto, Ronald Kiguba, Albert Figueras
Prescription of Levofloxacin and Moxifloxacin in Select Hospitals in Uganda: A Pilot Study to Assess Guideline Concordance. Antibiotics (Basel, Switzerland) 9 (8) (2020)
Helen Byomire Ndagije, Ronald Kiguba, Leonard Manirakiza, Elijah Kirabira, Allan Sserwanga, Leah Nabirye, Jackson Mukonzo, Sten Olsson, Anne Spinewine, William D'Hoore, Niko Speybroeck
Healthcare professionals' perspective can guide post-marketing surveillance of artemisinin-based combination therapy in Uganda. Malaria journal 19 (1) (2020)
Helen Byomire Ndagije, Leonard Manirakiza, Dan Kajungu, Edward Galiwango, Donna Kusemererwa, Sten Olsson, Anne Spinewine, Niko Speybroeck
The effect of community dialogues and sensitization on patient reporting of adverse events in rural Uganda: Uncontrolled before-after study. PloS one 14 (5) (2019)
Helen Byomire Ndagije, Victoria Nambasa, Leonard Manirakiza, Donna Kusemererwa, Dan Kajungu, Sten Olsson, Niko Speybroeck
The Burden of Adverse Drug Reactions Due to Artemisinin-Based Antimalarial Treatment in Selected Ugandan Health Facilities: An Active Follow-Up Study. Drug safety 41 (8) (2018)

Helen Byomire Ndagije.css-eqlu8i{font-size:small;padding-left:4px;} (Helen B Ndagije)

Publication Activity (10 Years)

Top Topics

Top Venues

Helen Byomire Ndagije (Helen B Ndagije)